NAM Journal

Elsevier

Journal websitePeer review: Peer review
Evaluation status available after sign-in

About the journal

NAM Journal is an open-access journal published by Elsevier in Netherlands, publishing in english. It is listed in DOAJ according to the sources read. Declared publication charge: 3,150 USD. Declared review time at DOAJ: 8 weeks. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.

Basic facts

Publisher
Elsevier
ISSN
3050-6204
Country
Netherlands
Languages
english
Access
Open access
Declared publication charge
3,150 USD
Articles in DOAJ
72
Declared review time
8 weeks
Declared peer-review model
peer_review

Index listings

  • DOAJ · 2026-03-09
Indexing
DOAJ
APC
3,150 USD
Declared review time (DOAJ)
8 weeks — journal-declared only (not measured)
Activity (OpenAlex)
Active — latest works 2026
PublishLens list status
Shown after sign-in
Counts for promotion at your university?
Choose your university and rank below ↓

Methodology signals (dated facts from their sources)

Details of the evaluation under the published methodology are shown to signed-in users (free).

Create a free account to view the evaluation

Journal profile

Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.

Articles in DOAJ

72

Most recent article

2 months ago

Average review time (journal-declared via DOAJ)

8weeks

Works in OpenAlex

104

Last recorded publication year

2026

Reported by OpenAlex in 1 of 3 sources (CC0 flags, not verified indexing)DOAJSciELOOpenAlex Core

h-index

6

i10-index

1

From OpenAlex open data (CC0).

Editorial & policy10
Added to DOAJ
2026-03-09
Declared plagiarism screening
Declared
Other fees beyond APC
No
Declared digital preservation
CLOCKSSPortico
Observed digital preservation (Keepers registry)— snapshot 2026-10-05
CLOCKSSPortico
Editorial board
Official page ↗
Open references deposited at Crossref
94%
ORCID iDs in current deposits
95%
Deposits licence metadata at Crossref
✓
APC waiver policy
View policy
Peer-review policy
View policy
Identity & continuity3
Alternate titles
NAM journal
Source type
journal
NLM unique ID (PubMed)
9919013695506676
Classification2

Subjects (DOAJ)

Medicine: Public aspects of medicine: Toxicology. Poisons

LCC codes

RA1190-1270

Subject areas

  • Animal testing and alternatives
  • Animal testing and alternatives
  • Effects and risks of endocrine disrupting chemicals
  • Effects and risks of endocrine disrupting chemicals
  • Computational Drug Discovery Methods
  • Carcinogens and Genotoxicity Assessment
  • Computational Drug Discovery Methods
  • Carcinogens and Genotoxicity Assessment
Show all subjects (50)
  • 3D Printing in Biomedical Research
  • Immunotoxicology and immune responses
  • Chemical Safety and Risk Management
  • Skin Protection and Aging
  • 3D Printing in Biomedical Research
  • Contact Dermatitis and Allergies
  • Immunotoxicology and immune responses
  • Contact Dermatitis and Allergies
  • Chemical Safety and Risk Management
  • Pesticide Exposure and Toxicity
  • Pesticide Exposure and Toxicity
  • Pluripotent Stem Cells Research
  • Skin Protection and Aging
  • Chemistry and Chemical Engineering
  • Pluripotent Stem Cells Research
  • Biomedical and Engineering Education
  • Biomedical and Engineering Education
  • Chemistry and Chemical Engineering
  • Occupational exposure and asthma
  • Pharmacogenetics and Drug Metabolism
  • Occupational exposure and asthma
  • Biomedical Ethics and Regulation
  • Toxic Organic Pollutants Impact
  • Toxic Organic Pollutants Impact
  • Per- and polyfluoroalkyl substances research
  • Biomedical Ethics and Regulation
  • Animal Genetics and Reproduction
  • Per- and polyfluoroalkyl substances research
  • Biotechnology and Related Fields
  • Inhalation and Respiratory Drug Delivery
  • Health Systems, Economic Evaluations, Quality of Life
  • Health and Medical Research Impacts
  • Neuroscience and Neural Engineering
  • Advancements in Transdermal Drug Delivery
  • Advancements in Transdermal Drug Delivery
  • Animal Genetics and Reproduction
  • Pharmacogenetics and Drug Metabolism
  • Neuroscience and Neural Engineering
  • Biotechnology and Related Fields
  • Health and Medical Research Impacts
  • Inhalation and Respiratory Drug Delivery
  • Health Systems, Economic Evaluations, Quality of Life

Keywords (DOAJ)

  • new approach methodologies (nams)
  • toxicology and safety testing
  • 21st century toxicity testing
  • in vitro and in silico methods
  • machine learning and artificial intelligence
  • replacement reduction and

Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.

Loading community confirmations…
How do we evaluate?Publisher of this journal? Appeal a derived assessment or request a factual correction

The journal's record in other sources:Web of Science MJLDOAJ

Everything shown here is produced automatically from named sources (DOAJ, OpenAlex, Crossref, PubMed, the Norwegian register) as of its capture date, with no human editing. Facts appear as recorded at the source; derived scores (PCI, PTD, PublishLens score) follow a published methodology. Not a judgement on the journal, not an official accreditation, not advice.

Wrong items are corrected automatically by re-reading the source (24 h for daily sources, 7 days for weekly ones) with a dated change log, and each item links to its source record. PublishLens-derived assessments are contested through the appeals mechanism (15 working days). Appeals · Indicator guide

Norwegian register data: Kanalregisteret (HK-dir, Norway) — CC BY 4.0 / NLOD — adapted: level extracted per year · OASPA member list — CC BY

Last automated source read: